LY134046
Product Specifications
UNSPSC Description
LY134046 is an inhibitor of norepinephrine N-methyltransferase (NMT) with cardiovascular activity. LY134046 causes sustained reductions in mean arterial blood pressure and heart rate, but no significant reductions in norepinephrine concentrations in the rat brain. LY134046 does not interact with adrenergic or cholinergic receptors, and its hypotensive and bradycardic effects do not require neurogenic tension. LY134046 (40 mg/kg/day) causes sustained and significant inhibition of hypothalamic and brainstem NMT activity, resulting in central norepinephrine depletion.
Target Antigen
N-myristoyltransferase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/ly134046.html
Smiles
ClC1=C2C(CCCNC2)=CC=C1Cl
Molecular Weight
216.11
References & Citations
[1]Hahn RA, et al. Cardiovascular effects of LY134046, an inhibitor of norepinephrine N-methyltransferase, in spontaneously hypertensive rats. J Pharmacol Exp Ther. 1983 Jul;226(1):39-45.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-136625/LY134046-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-136625/
Clinical Information
No Development Reported
CAS Number
71274-97-0
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
